
What do us physicians and patients think about LLTs and goals of treatment?
Physician and patient perceptions of benefits, risks, and treatment goals of lipid-lowering therapy: Results from GOULD registry.
This website contains promotional content and is intended for Healthcare Professionals
Physician and patient perceptions of benefits, risks, and treatment goals of lipid-lowering therapy: Results from GOULD registry.
This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).
Prescription patterns of lipidlowering therapies over time in patients with atherosclerotic cardiovascular disease: Findings from Gould study
Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.